All Pharmaceutical industry articles
View all stories with this category.
-
BusinessCan existing drugs slow Covid-19?
The fastest route to treatments may be to repurpose existing drugs – if they work
-
Business
Getting ideas across
In a diverse industry like chemicals, we need to make sure we’re open to learning from unexpected angles.
-
Opinion
Time for industry to show its humanity
Companies need to demonstrate community spirit in the face of the coronavirus pandemic
-
Business
Data is lacking as Reach moves beyond registration
Enforcing the demanding rules of Europe’s chemical legislation is keeping regulators and companies on their toes
-
Opinion
Why picking projects is like poker
Sometimes you prefer the high-risk, high-reward project to the ‘sure thing’
-
Business
FDA freezes foreign facility inspections amid coronavirus pandemic
US regulator will rely on border checks and shared data, but some approval processes may be delayed
-
Business
Coronavirus pandemic will disrupt international supply chains
Halted production and transport restrictions are straining industries that rely heavily on China for supplies
-
Business
RNA vaccines are coronavirus frontrunners
Several groups have potential Sars-CoV-2 vaccines ready or close to testing, thanks to rapid development pathways
-
Opinion
Two heads are better than one
Bifunctionals show that sometimes simply tethering two useful molecules together unlocks some useful activity
-
News
Number of industrial chemicals being produced globally grossly underestimated
Analysis of national chemical inventories finds three times as many chemicals registered for production as previously thought
-
Business
The race to fight coronavirus
While genome sequences enable testing and vaccine efforts, companies are donating existing antiviral drugs to explore repurposing
-
Research
Warning that 3D printing pills can stop drugs working
Photoreactive monomers need close scrutiny for production of polypills
-
Business
Cancer and rare diseases dominated 2019 drug approvals
More streamlined review processes and changing R&D priorities have contributed to sustained increase in new medicines
-
Business
Researchers call for stricter rules on drug-like medical devices
More oversight is needed over products in the grey area between medical device and medication
-
Opinion
Startup EQRx claims it can revolutionise drug discovery
If it can deliver reasonable drugs at knock-down prices, will providers be convinced?
-
Opinion
Reviewing performance reviews
Assessing the value of researchers’ work is hard, but there are some easy ideas to avoid
-
Business
Revived Alzheimer’s antibody met with guarded optimism
Biogen’s aducanumab offers the possibility to slow disease progress, but regulators will likely want more convincing evidence
-
Research
Compact pharmaceutical factory manufactures drugs on demand
Plant with modular design would occupy about half the area of a squash court
-
-
Business
Tissue scaffolds from resin inks
4D Medicine’s biodegradable polymer inks can be 3D-printed into useful biomedical applications
